PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.\', \'Institute of Clinical Pharmacy, Central South University, Changsha, China.\', \'The First Hospital of Changsha, Changsha, China.\', \'Department of Pharmacy, Wuhan University, Renmin Hospital, Wuhan, China.\', \'Department of Pharmacy, The Xiangya Hospital, Central South University, Changsha, China.\', \'Department of Radiology, The Second Xiangya Hospital, Central South University, Changsha, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/1440-1681.13425
?:doi
?:hasPublicationType
?:journal
  • Clinical and experimental pharmacology & physiology
is ?:pmid of
?:pmid
?:pmid
  • 33090501
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Comparative effectiveness of Lopinavir/Ritonavir-based regimens in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33090501>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33090501>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all